PSMA PET Imaging for Prostate Cancer Recurrence After Minimally Invasive Focal Therapy: A Single-Center Retrospective Study [0.03%]
前列腺癌微创消融治疗后复发的PSMA-PET影像评估：单中心回顾性研究
Mahbod Jafarvand,Andrea Farolfi,Riccardo Mei et al.
Mahbod Jafarvand et al.
Prostate-specific membrane antigen (PSMA)-targeted PET/CT (PSMA PET/CT) has become the first-line imaging modality used for staging and restaging prostate cancer. Its utility after minimally invasive focal therapy (high-intensity focused ul...
Reply LTE, Mathematical Discrepancies in the Per-Lesion Analysis of [68Ga]Ga-FAPI-46 and [18F]FDG PET/CT in Hepatic Lesions [0.03%]
关于[68Ga]Ga-FAPI-46和[18F]FDG PET/CT在肝病变中的病灶分析的数学差异的回复文章
Stanzel Susanne,Kuenzer Thomas,Jan Bucerius
Stanzel Susanne
Safety, Biodistribution, and Dosimetry of FAP and Integrin αvβ3 Dual-Targeting Radioligand 177Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas [0.03%]
靶向FAP和整合素αvβ3的放射配体¹⁷⁷卢-DOTA-FAPI-RGD的安全性、生物分布与剂量学：在晚期腺癌患者中的临床前验证及首次人体研究
Jialin Xiang,Xuejun Wen,Rongxi Wang et al.
Jialin Xiang et al.
Fibroblast activation protein (FAP) and integrin αvβ3 are attractive theranostic targets. We developed a dual-targeting radiotheranostic agent, 177Lu-DOTA-FAPI-RGD (177Lu-LNC1009), and conducted a first-in-human study to evaluate its safe...
The Global Theranostics Access Gap: Real-World Disparities in PSMA PET/CT and 177Lu-PSMA Therapy Between Centers in Brazil and Europe [0.03%]
全球放射治疗差距：巴西和欧洲中心在PSMA PET/CT和177Lu-PSMA治疗方面的现实差异
Juliano J Cerci,Stefano Fanti,Ken Herrmann et al.
Juliano J Cerci et al.
Real-world disparities in access to PSMA-targeted theranostics are poorly characterized. We compared waiting times for PSMA PET/CT and 177Lu-PSMA therapy between centers in Brazil and Europe. Methods: This retrospective multicenter study in...
68Ga-FAPI PET/CT for Differentiation of Malignant Peripheral Nerve Sheath Tumors, Neurofibromas, and Schwannomas [0.03%]
68镓-FAPI PET/CT在恶性外周神经鞘肿瘤、神经纤维瘤和施万细胞瘤之间的鉴别诊断中的应用
Anna-Maria Spektor,Marius Fried,Sergio A Zapata Bonilla et al.
Anna-Maria Spektor et al.
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft-tissue sarcomas that can develop either de novo or as a result of malignant transformation of neurofibromas. Diagnostic modalities of choice, such as MRI or 18F-FDG PET/C...
René R Sevag Packard
René R Sevag Packard
The Highlights Lecture, presented at the closing session of each SNMMI Annual Meeting, was originated and presented for more than 30 years by Henry N. Wagner, Jr., MD. Beginning in 2010, the duties of summarizing selected significant presen...